Advertisement
Screener

STERIS plc (STE) Right-of-Use Asset Obtained in Exchange for Operating Lease Liability

2.7 / 5 stars · 49/91 Roast Me

STERIS plc Right-of-Use Asset Obtained in Exchange for Operating Lease Liability

STERIS plc (STE) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $17.10 million for the 12-month period ending 2026-03-31, per its 10-K filed 2026-05-29.

Financial Statements › Notes › Leases

us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-05-29

  • STERIS plc right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2020-03-31 was $17.55M.
  • STERIS plc right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-12-31 was $13.97M.
  • STERIS plc right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-09-30 was $4.62M.
  • STERIS plc right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-06-30 was $8.51M.
  • STERIS plc right-of-use asset obtained in exchange for operating lease liability for fiscal 2026 was $17.10M, a 42.62% decline from fiscal 2025.
  • STERIS plc right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $29.80M, a 20.65% increase from fiscal 2024.
  • STERIS plc right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $24.70M, a 53.48% decline from fiscal 2023.
  • STERIS plc right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $53.10M, a 32.99% decline from fiscal 2022.
Period endRight-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 monthRight-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 monthRight-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 monthRight-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 monthRight-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month as first filed
2026-03-31$17.10M
10-K · filed 2026-05-29
2025-03-31$29.80M
10-K · filed 2026-05-29
$29.82M
10-K · filed 2025-05-29
2024-03-31$24.70M
10-K · filed 2026-05-29
$24.67M
10-K · filed 2024-05-29
2023-03-31$53.10M
10-K · filed 2025-05-29
2022-03-31$79.24M
10-K · filed 2024-05-29
2021-03-31$30.57M
10-K · filed 2022-05-31
2020-03-31$17.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-28
$31.51M
derived: sum of 2 quarters · filed 2021-05-28
$36.13M
derived: sum of 3 quarters · filed 2021-05-28
$44.64M
10-K · filed 2021-05-28
2019-12-31$13.97M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10
$18.58M
derived: sum of 2 quarters · filed 2020-02-10
$27.09M
10-Q · filed 2020-02-10
2019-09-30$4.62M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07
$13.12M
10-Q · filed 2019-11-07
2019-06-30$8.51M
10-Q · filed 2019-08-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
ZIMMER BIOMET HOLDINGS, INC. (ZBH)United States$17.103B20.66
ALIGN TECHNOLOGY INC (ALGN)United States$10.346B29.06
MSA Safety Inc (MSA)United States$7.023B21.47
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B